March 22, 2021 21:40 ET | Source: DelveInsight Business Research LLP DelveInsight Business Research LLP
Los Angeles, USA, March 22, 2021 (GLOBE NEWSWIRE) - Prostate cancer pipeline insight: a comprehensive analysis of key emerging therapies and pharmaceutical companies
DelveInsight stated that with more than 900 major pharmaceutical companies operating, the prostate cancer pipeline shows strong and promising prospects in the near future
DelveInsight's "Prostate Cancer Pipeline Insights" report focused on major breakthroughs in this field, and emerging therapies at different stages of clinical development, subdivided according to MoA, RoA, molecular type, drug delivery platform, etc.
Some key highlights from the report on the prostate cancer drug pipeline:
Request a sample@Prostate cancer treatment evaluation
Prostate cancer originates in the prostate near the bladder in the male pelvis. It is the second leading cause of death among American men from cancer, and approximately one in nine men will be diagnosed with prostate cancer in their lifetime. Prostatic hyperplasia can be benign (not cancer) or malignant (cancer).
Tomivosertib: Effect therapy Tomivosertib (also known as eFT508) is a new, effective and highly selective oral small molecule inhibitor that can inhibit mitogen-activated protein kinase interaction kinases 1 and 2, or collectively called MNK1/2. MNK1/2 plays a vital role in the development of many tumors, including controlling the expression of multiple factors that weaken the immune response in a coordinated manner.
Tomivosertib is currently in the second phase of development. This phase 2 study examined the efficacy, safety, tolerability, and pharmacokinetics (PK) of eFT508 (tomivosertib) in patients with metastatic castration-resistant prostate cancer. One-abiraterone, enzalutamide or apalutamide and people for whom there is no curative treatment. The main purpose of this study is to evaluate the anti-tumor response to eFT508 (tomivosertib) in mCRPC.
Have a deeper understanding of drug profiles, trials, and stages @Prostate Cancer Drug Pipeline
Overview of new drugs for prostate cancer
By phase and molecular typeBy phase and route of administrationBy phase and product type
Comprehensive understanding of pipeline analysis @Prostate cancer drug pipeline and emerging trends
Coverage: Major global players: Pfizer, Myovant Biosciences, Effector Therapeutics, Mediolanum, Merck, ESSA Pharma, Sanofi, Astellas, AstraZeneca, Bayer, Janssen Research and Development Co., Ltd., Bristol-Myers Squibb , Eli Lilly and Company, Amgen, POINT Biopharma, Hinnova Pharmaceuticals, Sophiris Bio, Ultimovacs, Foresee Pharmaceuticals, Luye Pharma Group, Abbott, AB science, Ferring Pharmaceuticals, Jiangsu Hengrui Pharmaceutical, Hoffmann-La Roche, Novartis, Celgene, Endocyte, Millennium Pharmaceuticals, Medivation, Veru, Progenics Pharmaceuticals, Boehringer Ingelheim, US Biotest, Antev, Elevation oncology, Abgenix, Astellas Pharma, Orion Pharma, Clovis Oncology, Exelixis, Takeda, Novus Therapeutics, Candel Therapeutics, Ipsen, MEI Pharma, Aragon Pharmaceuticals, MedImmune, CytRx, Tmunity Therapeutics, Inovio Pharmaceuticals, Luye Pharmaceutical, Health Ever Bio-Tech, Advaxis, Corcept Therapeutics, etc.
have a question? Get the answer @Prostate Cancer Emerging Therapy
Get a live demo of the report @ Prostate Cancer Pipeline Insights
Prostate Cancer Market DelveInsight's "Prostate Cancer Market Insights, Epidemiology and Market Forecasts in 2030" report.
Cervical cancer market DelveInsight's "Cervical Cancer-Market Insights, Epidemiology and Market Forecasts in 2030" report.
Multiple Myeloma Market DelveInsight's "Multiple Myeloma (MM)-Market Insights, Epidemiology and Market Forecast-2030" report.
Acral Melanoma Market DelveInsight's "Acral Melanoma Market Insights, Epidemiology and Market Forecast-2030" report.
Acute Lymphoblastic Leukemia Market DelveInsight's "Acute Lymphoblastic Leukemia Market Insights, Epidemiology and Market Forecast-2030" report.
Acute Myeloid Leukemia Market DelveInsight's "Acute Myeloid Leukemia (AML) Market Insights, Epidemiology and Market Forecast-2030" report.
Adenoid Cystic Carcinoma Market DelveInsight's "Adenoid Cystic Carcinoma Market Insights, Epidemiology and Market Forecasts in 2030" report.
Adult T-cell leukemia and lymphoma market DelveInsight's "Adult T-cell leukemia-lymphoma-2030 market insight, epidemiology and market forecast" report.
Advanced Liver Cancer Market DelveInsight's "Advanced Liver Cancer-2030 Market Insights, Epidemiology and Market Forecast" report.
Advanced Melanoma Market DelveInsight's "Advanced Melanoma-2030 Market Insights, Epidemiology and Market Forecast" report.
Advanced Pancreatic Cancer Market DelveInsight's "Advanced Pancreatic Cancer-2030 Market Insights, Epidemiology and Market Forecast" report.
Advanced Recurrent Ovarian Cancer Market DelveInsight's "Advanced Recurrent Ovarian Cancer-2030 Market Insights, Epidemiology and Market Forecast" report.
AIDS-related Kaposi's sarcoma market DelveInsight's "AIDS-related Kaposi's sarcoma-market insights, epidemiology and market forecasts in 2030" report.
DelveInsight is a leading business consultant and market research company, focusing on life sciences. It provides support to pharmaceutical companies by providing end-to-end comprehensive solutions to improve the performance of pharmaceutical companies. Easily access all healthcare and pharmaceutical market research reports through our subscription-based platform PharmDelve.